Aifstira IV 250 is an injectable drug containing Lonoctocog alpha (genetical recombination), manufactured by CSL Behring. It has a YJ code of 6343450D1027 and a standard of 250 IU x 1 bottle (with dissolving solution).
Aifstira IV 250
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).